share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

輝瑞 | 4:持股變動聲明-高管 JOHNSON RADY A
美股SEC公告 ·  11/02 03:27

牛牛AI助理已提取核心訊息

Rady A Johnson, Executive Vice President of Pfizer Inc (PFE), has executed a transaction involving the company's shares on October 31, 2024. The specific details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The action reflects a change in Johnson's investment in the company, but without further details, the impact on his total holdings remains unclear.
Rady A Johnson, Executive Vice President of Pfizer Inc (PFE), has executed a transaction involving the company's shares on October 31, 2024. The specific details of the transaction, including the number of shares, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The action reflects a change in Johnson's investment in the company, but without further details, the impact on his total holdings remains unclear.
輝瑞公司(PFE)執行副總裁Rady A Johnson於2024年10月31日完成了涉及公司股票的交易。交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值,並未在公告中披露。此舉反映了Johnson對公司投資的變化,但由於缺乏進一步細節,對其總持股的影響仍不明確。
輝瑞公司(PFE)執行副總裁Rady A Johnson於2024年10月31日完成了涉及公司股票的交易。交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值,並未在公告中披露。此舉反映了Johnson對公司投資的變化,但由於缺乏進一步細節,對其總持股的影響仍不明確。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。